Literature DB >> 29608181

The state of the art in the development of a panel of biomarkers for the early detection of lung cancer.

Fatemeh Rahimi Jamnani1,2.   

Abstract

Entities:  

Year:  2018        PMID： 29608181      PMCID： PMC5864595          DOI： 10.21037/jtd.2018.01.03

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.

Authors:  Yongjung Park; Yoonjung Kim; Jong-Han Lee; Eun Young Lee; Hyon-Suk Kim
Journal:  Arch Pathol Lab Med       Date:  2011-12       Impact factor: 5.534

2.  Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.

Authors:  Yibing Yao; Yu Fan; Jun Wu; Haisu Wan; Jing Wang; Stephen Lam; Wan L Lam; Luc Girard; Adi F Gazdar; Zhihao Wu; Qinghua Zhou
Journal:  Biochem Biophys Res Commun       Date:  2012-06-16       Impact factor: 3.575

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

4.  Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer.

Authors:  Xiao Yao; Hua Jiang; Cuizhen Zhang; Huamao Wang; Lin Yang; Yongfeng Yu; Junming Yu; Bizhi Shi; Zhijun Shen; Huiping Gao; Zhiwei Chen; Shujun Tian; Shun Lu; Zonghai Li; Jianren Gu
Journal:  Biomarkers       Date:  2010-03       Impact factor: 2.658

5.  Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status.

Authors:  Ingrid Broodman; Martijn M VanDuijn; Christoph Stingl; Lennard J M Dekker; Anastasios E Germenis; Harry J de Koning; Rob J van Klaveren; Joachim G Aerts; Jan Lindemans; Theo M Luider
Journal:  Cancer Immunol Res       Date:  2015-12-11       Impact factor: 11.151

6.  Anti-survivin antibody responses in lung cancer.

Authors:  Vaios Karanikas; Sanaa Khalil; Theodora Kerenidi; Konstantinos I Gourgoulianis; Anastasios E Germenis
Journal:  Cancer Lett       Date:  2009-04-19       Impact factor: 8.679

Review 7.  Non-small-cell lung cancer.

Authors:  Cesare Gridelli; Antonio Rossi; David P Carbone; Juliana Guarize; Niki Karachaliou; Tony Mok; Francesco Petrella; Lorenzo Spaggiari; Rafael Rosell
Journal:  Nat Rev Dis Primers       Date:  2015-05-21       Impact factor: 52.329

8.  Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma.

Authors:  Petra Leidinger; Andreas Keller; Nicole Ludwig; Stefanie Rheinheimer; Jürg Hamacher; Hanno Huwer; Ingo Stehle; Hans-Peter Lenhof; Eckart Meese
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

9.  Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.

Authors:  Yurong Chai; Xinxin Liu; Liping Dai; Yang Li; Mei Liu; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-03-19

10.  Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.

Authors:  Mehrdad Pazhouhandeh; Fatemeh Samiee; Tahereh Boniadi; Abbas Fadaei Khedmat; Ensieh Vahedi; Mahsa Mirdamadi; Naseh Sigari; Seyed Davar Siadat; Farzam Vaziri; Abolfazl Fateh; Faezeh Ajorloo; Elham Tafsiri; Mostafa Ghanei; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.